Dr. Xu is a Research Associate at the Wilmer Eye Institute in the Johns Hopkins University School of Medicine in Baltimore, MD. She completed her doctoral studies at the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China. Her research is focused on determining the neuroprotective role of Nrf2 in retinal ganglion cells (RGCs) and the potential of Nrf2 pharmacologic activation for the treatment of glaucoma.
Zhenhua Xu, PhD
First published on: June 11, 2015
Last modified on: November 21, 2024